Related references
Note: Only part of the references are listed.Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance
Maha Fahad Alenazy et al.
SCIENTIFIC REPORTS (2021)
IL10-and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T Cell Activation Through LAG-3 Expression
Marianna M. Koga et al.
FRONTIERS IN IMMUNOLOGY (2021)
Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis
Yingyuan Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis
Theresa L. Wampler Muskardin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Proportion of CD4+CD49b+LAG-3+ Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index
Jaehwan Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Decreased blood CD4+PD-1+and CD8+PD-1+T cells in psoriatic patients with and without arthritis
Joanna Bartosinska et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2018)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII
Takumi Maruhashi et al.
NATURE IMMUNOLOGY (2018)
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients
Joanna Bartosinska et al.
MEDIATORS OF INFLAMMATION (2017)
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Agnes Szentpetery et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis
Shinichiro Nakachi et al.
ARTHRITIS RESEARCH & THERAPY (2017)
T cell responses in psoriasis and psoriatic arthritis
Marco Diani et al.
AUTOIMMUNITY REVIEWS (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The impact of conventional DMARD and biological therapies on CD4+cell subsets in rheumatoid arthritis: a follow-up study
Balazs Szalay et al.
CLINICAL RHEUMATOLOGY (2014)
Anti-TNF-α therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis
Zhuochun Huang et al.
CELLULAR IMMUNOLOGY (2012)
Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab
Atsushi Ogata et al.
JOINT BONE SPINE (2012)
Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets
Octavio Aravena et al.
IMMUNOBIOLOGY (2011)
Combined Treatment of Etanercept and MTX Reverses Th1/Th2, Th17/Treg Imbalance in Patients with Rheumatoid Arthritis
Chen Lina et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Foxp3+ follicular regulatory T cells control the germinal center response
Michelle A. Linterman et al.
NATURE MEDICINE (2011)
Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept
Celine Blache et al.
RHEUMATOLOGY (2011)
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
L. C. Coates et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4
Seng-Ryong Woo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Maria-Grazia Roncarolo et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R. N. Maini et al.
ARTHRITIS AND RHEUMATISM (2006)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
X Valencia et al.
BLOOD (2006)
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2005)
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
H Yagi et al.
INTERNATIONAL IMMUNOLOGY (2004)
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells
CJ Workman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis
P Emery
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination
F Triebel
TRENDS IN IMMUNOLOGY (2003)
Share Paper
